Oncology Central

The thrills and agonies of using next-generation sequencing for somatic mutation detection in cancer

0

In the 1990s, the field of molecular biology was catapulted into the diagnostic arena as the PCR technology offered performance characteristics and turnaround times more suitable for a clinical laboratory setting than all previous molecular techniques. Over the next 10 years, limitations of the PCR were quickly overcome by the introduction of real-time PCR chemistries and instruments that automated amplification and detection, as well as sample extraction in some turnkey platforms [1].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.